Taipei LedgerData Analysis on Taiwan's Companies and Economy

Company profile · Biotech & medical

Energenesis Biomedical

華安醫學股份有限公司 · 6657

What it does

Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.

Energenesis Biomedical develops new drugs using its proprietary ENERGI drug development platform to activate AMP-activated protein kinase, a key enzyme in cellular energy regulation, as a method for disease treatment.[1]

The company focuses on biomedical intellectual property development, utilizing internally researched and developed new drug technologies and patents, with a business model centered on technology licensing to domestic and international pharmaceutical companies following clinical trial validation.[2]

Its development pipeline includes new drug candidates such as ENERGI-F703EB cream for epidermolysis bullosa, and treatments for diabetic foot ulcers.[3]

Based in Taipei, Taiwan, the company was established in 2012 and qualified as a biotech new drug company by the Ministry of Economic Affairs in 2015.[1]

Monthly revenue

Latest monthRevenueYear on yearMonth on month
2026-10NT$0m-66.1%-11.1%
2024-11: NT$0.00bn2024-12: NT$0.00bn2025-01: NT$0.00bn2025-02: NT$0.00bn2025-03: NT$0.00bn2025-04: NT$0.00bn2025-05: NT$0.00bn2025-06: NT$0.00bn2025-07: NT$0.00bn2025-08: NT$0.00bn2025-09: NT$0.00bn2025-10: NT$0.00bn2025-11: NT$0.00bn2025-12: NT$0.00bn2026-01: NT$0.00bn2026-02: NT$0.00bn2026-03: NT$0.00bn2026-04: NT$0.00bn2026-05: NT$0.00bn2026-06: NT$0.00bn2026-07: NT$0.00bn2026-08: NT$0.00bn2026-09: NT$0.00bn2026-10: NT$0.00bn

2024-11 to 2026-10, monthly revenue.

Foreign investors

Last 20 trading daysNet
2026-10-12 to 2026-11-10−NT$3m
2026-10-12: −NT$2m2026-10-13: +NT$1m2026-10-14: −NT$1m2026-10-15: −NT$1m2026-10-16: +NT$0m2026-10-19: −NT$1m2026-10-20: +NT$0m2026-10-21: +NT$0m2026-10-22: +NT$2m2026-10-27: −NT$0m2026-10-28: −NT$0m2026-10-29: −NT$0m2026-10-30: −NT$0m2026-11-02: −NT$0m2026-11-03: −NT$1m2026-11-04: +NT$1m2026-11-05: −NT$1m2026-11-06: −NT$1m2026-11-09: +NT$1m2026-11-10: −NT$1m

Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.

Facts

Full English nameEnergenesis Biomedical CO.,LTD.
Chinese name華安醫學股份有限公司
Stock code6657 (TWSE)
IndustryBiotech & medical
Founded28 Aug 2012
Listed12 Jun 2023
Paid-in capitalNT$897m
Chairman陳翰民
President江銘燦
Headquarters6F.-3, No.21, Ln.583, Ruiguang Rd., Neihu Dist., Taipei 11492, Taiwan
Websitehttp://www.energenesis-biomedical.com
Official business description新藥開發 · 檢測分析服務及試劑銷售

Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.

Sources

  1. MOPS 公司基本資料 華安醫學股份有限公司 · mops · retrieved 04 Nov 2026
  2. 公司簡介 | 關於我們 · website · retrieved 04 Nov 2026
  3. 華安醫學股份有限公司 · website · retrieved 04 Nov 2026
The Week in Taiwan Companies · free, every Friday
Using it at work? Join the team-plan waiting list

Generated 2026-11-11 00:39.